BioMarin to acquire Amicus Therapeutics for $4.8 billion ○
found
You are not logged in so some information on this page has been withheld. To see more, please log in or sign up.
Pharmaceutical
since
auto-detected in 3 stories
70 days ago
BioMarin Pharmaceutical said on Friday it would acquire Amicus Therapeutics for about $4.8 billion, expanding its presence in rare metabolic diseases.
10 months ago
Trump pharma tariffs would raise U.S. drug costs by $51 billion annually, report finds ○
found
Pharmaceutical Research and Manufacturers of America includes Amgen, Bristol Myers Squibb, Eli Lilly, and Pfizer, among others.
12 months ago
AstraZeneca cancels £450m Liverpool investment, blaming UK government funding cuts – business live ○
Pharmaceutical company says that it will not go ahead with investment at Speke, near Liverpool
Donald Trump’s White House will invoke emergency powers to introduce tariffs on Canada and Mexico, Reuter…
page 1 of 1